Great Debate: Limb Infusion for Melanoma: A Thing of the Past?
Ann Surg Oncol
.
2023 Oct;30(11):6319-6324.
doi: 10.1245/s10434-023-13765-0.
Epub 2023 Jul 17.
Authors
Kristen E Rhodin
1
,
Douglas S Tyler
2
,
Jonathan S Zager
3
4
,
Georgia M Beasley
5
6
Affiliations
1
Department of Surgery, Duke University School of Medicine, Durham, NC, USA.
2
Department of Surgery, University of Texas Medical Branch, Galveston, TX, USA.
3
Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL, USA.
4
Department of Oncologic Sciences, University of South Florida Morsani College of Medicine, Tampa, FL, USA.
5
Department of Surgery, Duke University School of Medicine, Durham, NC, USA. Georgia.beasley@duke.edu.
6
Department of Medicine, Duke University School of Medicine, Durham, NC, USA. Georgia.beasley@duke.edu.
PMID:
37458946
DOI:
10.1245/s10434-023-13765-0
No abstract available
MeSH terms
Chemotherapy, Cancer, Regional Perfusion
Extremities
Humans
Melanoma* / drug therapy
Melphalan / therapeutic use
Skin Neoplasms* / drug therapy
Skin Neoplasms* / surgery
Substances
Melphalan
Grants and funding
1R38AI140297/National Institute of Allergy and Infectious Diseases